Thank you for subscribing!
Finfeed Archived Jan 19, 2021
Creso Pharma Limited (ASX:CPH; FRA:1X8) continues to build a strong revenue platform for 2021, advising today that it has received two new purchase orders (POs) for its anibidiol® line of animal health products totalling A$247,826. Together, the total value of combined orders represents over A$1M.
Get expert stock analysis direct in your inbox
Join Our Mailing List